At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

News from this company


2024 Guidance Suspended: API Production Paused in Brindisi, Italy

19.03.2024 -

EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.


EuroAPI Collaborates with Contract Research Organization SpiroChem

26.01.2024 -

Active pharmaceutical ingredients manufacturer EuroAPI has started a collaboration with Basel, Switzerland-headquartered SpiroChem, a contract research organization (CRO)...


EuroAPI Completes Acquisition of BianoGMP

22.11.2023 -

EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.


EuroAPI Announces New Governance

26.10.2023 -

EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane...

Chemistry & Life Sciences

Ensuring API Supply Capacities for Europe and Beyond

13.10.2022 -

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.



15 rue Traversière
75012 Paris